<?xml version="1.0" encoding="UTF-8"?>
<document id="29309627">
	<sentence id="s1" text="The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor spinal cord motor neuron cell fate specification that interacts with activation of innate immune response/p54NRB, a survival factor.">
		<entity id="s1.e1" charOffset="48-54"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="56-67"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<entity id="s1.e3" charOffset="207-255"
			type="GO" text="spinal cord motor neuron cell fate specification" ontology_id="GO_0021520"/>
		<entity id="s1.e4" charOffset="276-312"
			type="GO" text="activation of innate immune response" ontology_id="GO_0002218"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p3" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p4" e1="s1.e5"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Also, two somatic heterozygous activation of innate immune response mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).">
		<entity id="s2.e1" charOffset="31-67"
			type="GO" text="activation of innate immune response" ontology_id="GO_0002218"/>
		<entity id="s2.e2" charOffset="110-116"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="184-189"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Overall, our results highlight the importance of spinal cord motor neuron cell fate specification in conditions of β-cell excess (insulinomas) and in conditions of β-cell loss or dysfunction (diabetes).">
		<entity id="s3.e1" charOffset="49-97"
			type="GO" text="spinal cord motor neuron cell fate specification" ontology_id="GO_0021520"/>
		<entity id="s3.e2" charOffset="130-141"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Our studies implicate therapeutic strategies for either reducing β-cell proliferation in insulinomas or alleviating normal β-cell deficiency in diabetes through the modulation of spinal cord motor neuron cell fate specification phosphorylation">
		<entity id="s4.e1" charOffset="89-100"
			type="HP" text="insulinomas" ontology_id="HP_0012197"/>
		<entity id="s4.e2" charOffset="179-227"
			type="GO" text="spinal cord motor neuron cell fate specification" ontology_id="GO_0021520"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
</document>
